深圳数据交易所发力“医数融合” 赋能药械高质量发展

Group 1 - The AI-enabled Shenzhen Pharmaceutical and Medical Device Industry High-Quality Development Conference successfully took place, focusing on how data and algorithms can assist in drug and medical device research, precision medicine, and health management [1] - The conference marked the launch of the "Clinical Empowerment for Ten Million Population Scenarios" platform, establishing Shenzhen as a leader in creating an AI medical application ecosystem covering a super-large city population [1] - The platform aims to enhance the efficient collaboration of medical resources and accelerate the application of AI drug and medical device technologies from laboratories to real-life scenarios [1] Group 2 - The Shenzhen Data Exchange's establishment is a key initiative for implementing the Shenzhen Comprehensive Reform Pilot Plan (2020-2025), focusing on data empowerment for high-quality economic development [2] - The Shenzhen Data Exchange has created a full-process service system for data rights confirmation, pricing, trading, usage, and regulation, aiming to explore market-oriented data element allocation paths [2] - Five high-quality medical data products were listed at the event, focusing on public health, chronic disease management, vaccination, and treatment behaviors, providing a solid data foundation for AI drug and medical device companies [2] Group 3 - Huasheng Medical, the first certified data vendor in the medical device sector at the Shenzhen Data Exchange, has launched both data set and data tool assets, creating a complete value chain from "data raw materials" to "intelligent tools" [3] - The company aims to collaborate with China Unicom, Shenzhen Data Exchange, and hospitals to enhance hardware and data training, providing more intelligent devices [3]